Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 4
Background: To compare efficacy of high versus low–medium prednisone doses for the treatment of systemic lupus erythematosus patients. Materials and Methods: Seventy- four adults patients diagnosed with systemic lupus erythematosus of either gender was divided equally (37) into 2 groups. Group I received prednisone doses ≤30 mg/day and group II received prednisone doses >30 mg/day. Activity was measured using the SLEDAI-2K score. Damage accrual was calculated using the SLICC damage index (SDI).